Loading…
Terumo Corporation reached an agreement to acquire St. Jude Medical's Angio-Seal and FemoSeal vascular closure products and Abbott's Vado steerable sheath business (via Kalila Medical) for $1.12 billion.
The European Commission granted conditional approval for Abbott's $25 billion acquisition of St. Jude Medical, requiring the divestiture of St. Jude's Angio-Seal and Femoseal vascular closure assets and Abbott's Vado steerable sheath, which are already slated for sale to Terumo for $1 billion.
The European Commission approved Abbott Laboratories' $25 billion cash-and-stock acquisition of St. Jude Medical, conditional on Abbott divesting two devices used in cardiovascular treatments.